The Daily Buyout
UndisclosedStrategic acquisitionHealthcare & Life SciencesCompleted

EMD Serono Acquires PostEra's Two Fertility Drug Programs

EMD Serono, the US/Canada healthcare business of Merck KGaA, acquired two of PostEra's AI-discovered small molecule fertility programs targeting FSHR and LHCGR.

Read the full coverage, free

We only link to sources you can read without a subscription. How we check.

More Healthcare & Life Sciences deals